Atacicept

Tax included
Atacicept (TACI-Ig) is a is a recombinant fusion protein containing the extracellular, ligand-binding portion of the TACI receptor and the Fc portion of human IgG. Atacicept inhibits B cell stimulation by binding to B lymphocyte stimulator and a proliferation-inducing ligand. Atacicept can be used in research of B-cell autoimmune disease.
HY-P99446

Data sheet

Size
Multiple sizes
Reactivity
Others
Application
COVID-19-immunoregulation
CAS
845264-92-8